Stock AGL ANGLE PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases ANGLE plc

Equities

AGL

GB0034330679

Market Closed - London S.E.
Other stock markets
 11:35:27 2024-06-07 am EDT 		5-day change 1st Jan Change
15 GBX 0.00% Intraday chart for ANGLE plc -20.00% +27.66%
Jun. 05 Angle plc to Raise GBP10.6 Million via Share Placing, Subscription, Open Offer MT
Jun. 05 ANGLE plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant
AQ
ANGLE PLC - NEW COMMERCIAL AGREEMENT WITH LARGE PHARMA
AQ
ANGLE partners with AstraZeneca in groundbreaking oncology contract
AQ
ANGLE PLC - US AND EU PATENTS FOR ANGLE'S INNOVATIVE CELLKEEP SLIDE
AQ
ANGLE achieves breakthrough with EU patent for CellKeep technology, with the US to follow
AQ
ANGLE PLC - PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE
AQ
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY
AQ
ANGLE PLC - PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE
AQ
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY
AQ
ANGLE PLC - BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCER
AQ
ANGLE LAUNCHES PORTRAIT+ CTC KIT AT SAN ANTONIO BREAST CANCER SYMPOSIUM
AQ
ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIES
AQ
ANGLE PLC - TRADING AND BUSINESS UPDATE
AQ
ANGLE PLC - RESEARCH DEMONSTRATES POTENTIAL OF THE PARSORTIX SYSTEM TO SUPPORT POWERFUL CHARACTERISATION OF CTCS IN HEAD AND NECK CANCER
AQ
ANGLE PLC - PARSORTIX SYSTEM OUTPERFORMS CURRENT LABORATORY STANDARD FOR DISSEMINATED TUMOUR CELL HARVEST
AQ
Angle Plc - Launch of Portrait Flex Circulating Tumor Cell Assay
AQ
ANGLE : Annual Report December 2022
PU
ANGLE PLC has opened up "a major market opportunity" with breast cancer partnership
AQ
ANGLE : Interim Report June 2022
PU
Presentation slides 29 September 2022: Interim Results for the Six Months Ended 30 June 2022
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGL Stock
  4. News ANGLE plc
  5. Press Releases